Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference14 articles.
1. Improving the care and treatment of monkeypox patients in low-resource settings: applying evidence from contemporary biomedical and smallpox biodefense research;Reynolds;Viruses,2017
2. Prevention and treatment of monkeypox;Rizk;Drugs,2022
3. The disease ecology, epidemiology, clinical manifestations, management, prevention, and Control of increasing human infections with animal orthopoxviruses;Diaz;Wilderness Environ. Med.,2021
4. RF-potential treatments for monkeypox;Rodríguez-Cuadrado;Actas Dermosifiliogr,2022
5. The development and approval of tecoviromat (TPOXX®), the first antiviral against smallpox;Merchlinsky;Antivir. Res.,2019
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Successful Treatment of Recalcitrant Mpox Lesions With Intralesional Cidofovir in a Patient With HIV/AIDS;JAMA Dermatology;2023-12-06
2. Monkeypox virus (MPXV): A Brief account of global spread, epidemiology, virology, clinical features, pathogenesis, and therapeutic interventions;Infectious Medicine;2023-12
3. Knowledge, Attitudes, and Willingness of Healthcare Workers in Iraq’s Kurdistan Region to Vaccinate against Human Monkeypox: A Nationwide Cross-Sectional Study;Vaccines;2023-11-21
4. Entropy-Driven, Integrative Bioinformatics Approaches Reveal the Recent Transmission of the Monkeypox Virus from Nigeria to Multiple Non-African Countries;Molecular Biotechnology;2023-10-05
5. Comparison of the binding energies of approved mpox drugs and phytochemicals through molecular docking, molecular dynamics simulation, and ADMET studies: An in silico approach;Journal of Biosafety and Biosecurity;2023-09